0

Amlodipine Besylate Market by Application and Geography - Forecast and Analysis 2022-2026

  • Published: Jun 2022
  • Pages: 116
  • SKU: IRTNTR73747
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The amlodipine besylate market share is expected to increase to USD 217.26 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 3.6%.

This amlodipine besylate market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers amlodipine besylate market segmentations by application (high blood pressure and heart diseases) and geography (North America, Europe, Asia, and Rest of World (ROW)). The amlodipine besylate market report also offers information on several market vendors, including Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., and Orbion Pharmaceuticals Pvt. Ltd. among others.

What will the Amlodipine Besylate Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Amlodipine Besylate Market Size for the Forecast Period and Other Important Statistics

 

Amlodipine Besylate Market: Key Drivers, Trends, and Challenges

The rising incidence of hypertension is notably driving the amlodipine besylate market growth, although factors such as side effects on human health may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the amlodipine besylate industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Amlodipine Besylate Market Driver

  • The rising incidence of hypertension is one of the key drivers supporting the amlodipine besylate market growth.
  • Fundamentally, the effective implementation of guidelines for treating coronary artery disease depends on a number of factors, including the availability of the guidelines and the availability of skilled personnel to carry out their recommendations.
  • According to the World Health Organization (WHO), heart disease is one of the most common causes of death in the world, and it is particularly common in low- and middle-income countries.  
  • The growth of the amlodipine besylate market is mainly due to the increasing consumption of alcohol, tobacco products, and junk food.
  • According to the WHO, it is estimated that 1.13 billion people suffer from hypertension worldwide. Thus, the rising incidence of hypertension will drive the amlodipine besylate market growth during the forecast period.

Key Amlodipine Besylate Market Trend

  • Increasing usage of amlodipine besylate in various treatments is one of the key amlodipine besylate market trends contributing to the market growth.
  • Amlodipine Besylate is used to treat conditions such as high blood pressure, angina, and coronary heart disease.
  • Amlodipine besylate belongs to a class of calcium channel blockers that inhibit the entry of calcium into the slow channels of the myocardium and vascular smooth muscle during depolarization, which causes relaxation of coronary vasodilation and coronary smooth muscle.
  • Amlodipine is used to prevent angina, which can be a sign of a heart problem. It may help to increase the ability to exercise and decrease the frequency of angina attacks in high-blood-pressure patients.
  • Amlodipine is safe to use during pregnancy and this is likely to fuel the growth of the global amlodipine besylate market during the forecast period.

Key Amlodipine Besylate Market Challenge

  • Side effects on human health is one of the factors hampering the amlodipine besylate market growth.
  • Amlodipine besylate can cause various side effects to humans including hives, allergic reactions, difficulty breathing, and others.
  • Significantly, it is advisable to get medical attention when the symptoms arise such as pounding heartbeats and chest flutters, exacerbation of chest pain, and others.

Thus, such life-threatening side effects may hamper the amlodipine besylate market growth during the forecast period.

This amlodipine besylate market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the amlodipine besylate market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the amlodipine besylate market during the forecast period.

Who are the Major Amlodipine Besylate Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Amsal Chem Pvt. Ltd.
  • Aurobindo Pharma Ltd.
  • Cadila Pharmaceuticals Ltd.
  • CENTURY PHARMACEUTICALS Ltd.
  • Cipla Ltd.
  • Dr. Reddys Laboratories Ltd.
  • MOEHS IBERICA SL
  • Rakshit Drugs Pvt. Ltd.
  • VPL Chemicals Pvt. Ltd.
  • Changzhou Yabang Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Apotex Inc.
  • Lupin Ltd.
  • Strides Pharma Science Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Chartwell Pharmaceuticals LLC
  • Synthon International Holding BV
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Ltd.
  • Orbion Pharmaceuticals Pvt. Ltd.

 

This statistical study of the amlodipine besylate market encompasses successful business strategies deployed by the key vendors. The amlodipine besylate market is fragmented and the vendors are deploying growth strategies such as developing cost-effective products, mergers and acquisitions, robust research and development, and geographical expansion to compete in the market.

Product Insights and News

  • Amsal.com - The company offers amlodipine besylate used for hypertensive and anginal conditions.
  • Cadilapharma.com - The company offers amlodipine besylate tablets which are used for the treatment of hypertension.
  • Centurypharma.com - The company offers amlodipine besylate used for hypertensive and anginal condition.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The amlodipine besylate market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Amlodipine Besylate Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the amlodipine besylate market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Amlodipine Besylate Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the amlodipine besylate market in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

Huge investments in the pharmaceutical business will facilitate the amlodipine besylate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

 In 2020, the outbreak of COVID-19 negatively impacted the regional market. However, in 2021, the initiation of vaccination drives contributed to the containment of the disease. This has eventually led to the lifting of lockdowns and the resumption of all the previously closed public and private business units in the region. Thus, such factors are expected to drive the growth of the amlodipine besylate market during the forecast period.

What are the Revenue-generating Application Segments in the Amlodipine Besylate Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The amlodipine besylate market share growth by the high blood pressure segment will be significant during the forecast period. High blood pressure is a common problem that can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. If not treated, high blood pressure can lead to serious health problems, such as heart attack, heart failure, stroke, kidney failure, and loss of vision. A high blood pressure patient must continue taking amlodipine even if they feel well. Such medication for high blood pressure will drive the amlodipine besylate market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the amlodipine besylate market size and actionable market insights on post COVID-19 impact on each segment.

 

Amlodipine Besylate Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 3.6%

Market growth 2022-2026

$ 217.26 million

Market structure

Fragmented

YoY growth (%)

3.0

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., and Orbion Pharmaceuticals Pvt. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Amlodipine Besylate Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive amlodipine besylate market growth during the next five years
  • Precise estimation of the amlodipine besylate market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the amlodipine besylate industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of amlodipine besylate market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Application

    • 5.1 Market segments
      • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
    • 5.2 Comparison by Application
      • Exhibit 26: Chart on Comparison by Application
      • Exhibit 27: Data Table on Comparison by Application
    • 5.3 High blood pressure - Market size and forecast 2021-2026
      • Exhibit 28: Chart on High blood pressure - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on High blood pressure - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on High blood pressure - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on High blood pressure - Year-over-year growth 2021-2026 (%)
    • 5.4 Heart diseases - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Heart diseases - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Heart diseases - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Heart diseases - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Heart diseases - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Application
      • Exhibit 36: Market opportunity by Application ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Amsal Chem Pvt. Ltd.
              • Exhibit 85: Amsal Chem Pvt. Ltd. - Overview
              • Exhibit 86: Amsal Chem Pvt. Ltd. - Product / Service
              • Exhibit 87: Amsal Chem Pvt. Ltd. - Key offerings
            • 10.4 Aurobindo Pharma Ltd.
              • Exhibit 88: Aurobindo Pharma Ltd. - Overview
              • Exhibit 89: Aurobindo Pharma Ltd. - Product / Service
              • Exhibit 90: Aurobindo Pharma Ltd. - Key offerings
            • 10.5 Cadila Pharmaceuticals Ltd.
              • Exhibit 91: Cadila Pharmaceuticals Ltd. - Overview
              • Exhibit 92: Cadila Pharmaceuticals Ltd. - Business segments
              • Exhibit 93: Cadila Pharmaceuticals Ltd. - Key offerings
              • Exhibit 94: Cadila Pharmaceuticals Ltd. - Segment focus
            • 10.6 CENTURY PHARMACEUTICALS Ltd.
              • Exhibit 95: CENTURY PHARMACEUTICALS Ltd. - Overview
              • Exhibit 96: CENTURY PHARMACEUTICALS Ltd. - Product / Service
              • Exhibit 97: CENTURY PHARMACEUTICALS Ltd. - Key offerings
            • 10.7 Changzhou Yabang Pharmaceutical Co. Ltd.
              • Exhibit 98: Changzhou Yabang Pharmaceutical Co. Ltd. - Overview
              • Exhibit 99: Changzhou Yabang Pharmaceutical Co. Ltd. - Product / Service
              • Exhibit 100: Changzhou Yabang Pharmaceutical Co. Ltd. - Key offerings
            • 10.8 Cipla Ltd.
              • Exhibit 101: Cipla Ltd. - Overview
              • Exhibit 102: Cipla Ltd. - Business segments
              • Exhibit 103: Cipla Ltd. - Key news
              • Exhibit 104: Cipla Ltd. - Key offerings
              • Exhibit 105: Cipla Ltd. - Segment focus
            • 10.9 Dr. Reddys Laboratories Ltd.
              • Exhibit 106: Dr. Reddys Laboratories Ltd. - Overview
              • Exhibit 107: Dr. Reddys Laboratories Ltd. - Business segments
              • Exhibit 108: Dr. Reddys Laboratories Ltd. - Key offerings
              • Exhibit 109: Dr. Reddys Laboratories Ltd. - Segment focus
            • 10.10 MOEHS IBERICA SL
              • Exhibit 110: MOEHS IBERICA SL - Overview
              • Exhibit 111: MOEHS IBERICA SL - Product / Service
              • Exhibit 112: MOEHS IBERICA SL - Key offerings
            • 10.11 Rakshit Drugs Pvt. Ltd.
              • Exhibit 113: Rakshit Drugs Pvt. Ltd. - Overview
              • Exhibit 114: Rakshit Drugs Pvt. Ltd. - Product / Service
              • Exhibit 115: Rakshit Drugs Pvt. Ltd. - Key offerings
            • 10.12 VPL Chemicals Pvt. Ltd.
              • Exhibit 116: VPL Chemicals Pvt. Ltd. - Overview
              • Exhibit 117: VPL Chemicals Pvt. Ltd. - Product / Service
              • Exhibit 118: VPL Chemicals Pvt. Ltd. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 119: Inclusions checklist
                • Exhibit 120: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 121: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 122: Research methodology
                • Exhibit 123: Validation techniques employed for market sizing
                • Exhibit 124: Information sources
              • 11.5 List of abbreviations
                • Exhibit 125: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The amlodipine besylate market market growth will increase by $$ 217.26 mn during 2023-2026.
              The amlodipine besylate market market is expected to grow at a CAGR of 3.6% during 2023-2026.
              Technavio has segmented the amlodipine besylate market market by application (High blood pressure and Heart diseases) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Orbion Pharmaceuticals Pvt. Ltd. are a few of the key vendors in the amlodipine besylate market market.
              North America will register the highest growth rate of 39% among the other regions. Therefore, the amlodipine besylate market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the amlodipine besylate market market growth are:
              • Rising incidence of hypertension
              • Increasing usage of amlodipine besylate in various treatments
              The amlodipine besylate market market vendors should focus on grabbing business opportunities from the high blood pressure segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>